A5073230810- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Pancreatitis Pathology and Treatment
- Gastroesophageal reflux and treatments
- COVID-19 and healthcare impacts
- Pediatric Hepatobiliary Diseases and Treatments
- Medical Imaging and Pathology Studies
- Palliative Care and End-of-Life Issues
- Esophageal and GI Pathology
- Liver Disease Diagnosis and Treatment
- Colorectal Cancer Screening and Detection
- Cardiac, Anesthesia and Surgical Outcomes
Indiana University – Purdue University Indianapolis
2020
Indiana University School of Medicine
2020
Indiana University
2020
University of Toronto
2020
Objectives A proteomic discovery study was performed to determine if urine possesses a unique biosignature that could form the basis for noninvasive test able predict intraductal papillary mucinous neoplasm (IPMN) dysplasia. Methods Urine collected from patients undergoing surgery IPMN (72 low/moderate, 27 high-grade/invasive). Quantitative mass spectrometry-based proteomics performed. Proteins of interest were identified by differential expression analysis followed principal component...
The accuracy of hepatobiliary scintigraphy to assess gallbladder function remains controversial. National supply shortages pharmaceutical-grade cholecystokinin led the use an oral fatty meal stimulate contraction during scintigraphy. goal this study was compare predictive indices and ingestion for stimulation contraction.Patients evaluated with iminodiacetic acid scan from 2014 2017 were reviewed grouped based on testing stimulant (fatty versus cholecystokinin). Patients who later underwent...